Angelo Delmonte

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Sungkyunkwan University(Current)

Samsung Medical Center

The Christie NHS Foundation Trust

University of Manchester

Vall d'Hebron Hospital Universitari

Angelo Delmonte is an author at Sungkyunkwan University specializing in lung cancer pharmacotherapy, oncology, and anaplastic lymphoma kinase inhibition.

ORCID

Publications per year

2022–2025

Publications

Efficacy and Safety of Brigatinib Compared With Crizotinib in Asian vs. Non-Asian Patients With Locally Advanced or Metastatic ALK–Inhibitor-Naive ALK+ Non–Small Cell Lung Cancer: Final Results From the Phase III ALTA-1L Study

Myung‐Ju Ahn, Hye Ryun Kim, James Chih‐Hsin Yang et al. · Clinical Lung Cancer · 2022 · 53 citations · Full text

Medicine, Oncology, Pharmacology +15

Single-Agent Divarasib in Patients With <i>KRAS G12C</i> –Positive Non–Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study

Adrian G. Sacher, Wilson H. Miller, Manish R. Patel et al. · Journal of Clinical Oncology · 2025 · 21 citations · Full text

Medicine, Oncology, Pharmacology +16

1–2 of 2